Juan Tamargo
Universidad Complutense de Madrid
H-index: 85
Europe-Spain
Top articles of Juan Tamargo
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect | Juan Tamargo Julián Villacastín Ricardo Caballero Eva Delpón | 2024/1/19 | |
Reply to Benndorff and DiFrancesco: Reliable human HCN4 single-channel recordings using the cell-attached configuration in expression systems | Proceedings of the National Academy of Sciences | Anabel Cámara-Checa Marcos Rubio-Alarcón María Dago Teresa Crespo-García Josu Rapún | 2024/4/16 |
Coexistent HCN4 and GATA5 rare variants and Atrial Fibrillation in a large Spanish Family | Canadian Journal of Cardiology | Alfonso Fraile Jorge Cebrián Israel Thuissard-Vasallo Sara Pérez-Martín Raquel Casado | 2024/3/1 |
Are NOACs always the best strategy in elderly AF patients? | Moritake Iguchi Juan Tamargo Koji Hasegawa | 2024/3 | |
An Account on the History of Pharmacology in Spain | Ana María Aldea-Perona Jesús Flórez Beledo Jesús Frías Iniesta Antonio G García Juan Tamargo | 2024/2/14 | |
New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022 | Juan Tamargo Stefan Agewall Claudio Borghi Claudio Ceconi Elisabetta Cerbai | 2023/6 | |
Erratum: Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on … | Erratum: Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy (European Heart Journal—Cardiovascular Pharmacother | Juan Tamargo Keld Per Kjeldsen Eva Delpon Anne Grete Semb Elisabett Cerbai | 2023 |
Triglycerides revisited: is hypertriglyceridaemia a necessary therapeutic target in cardiovascular disease? | Heinz Drexel Juan Tamargo Juan Carlos Kaski Basil S Lewis Christoph H Saely | 2023/9 | |
Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish … | Endocrinología, Diabetes y Nutrición (English ed.) | Juan Pedro-Botet Vivencio Barrios Víctor Sánchez-Margalet Juan Tamargo Francisco Arrieta | 2023/3/1 |
Substance-based medical devices for human health: a challenge of efficacy, safety, and sustainability | Frontiers in Drug Safety and Regulation | Alessandro Mugelli Juan Tamargo | 2023/5/31 |
How important it is to know the preferences of the diabetic patient | International Journal of Cardiology | Juan Tamargo | 2023/1/1 |
Herbal medicines for the treatment of cardiovascular diseases: Benefits and risks–A narrative review | Lucinda Villaescusa Cristina Zaragoza Francisco Zaragoza Juan Tamargo | 2023/8/15 | |
A gain-of-function HCN4 mutant in the HCN domain is responsible for inappropriate sinus tachycardia in a Spanish family | Proceedings of the National Academy of Sciences | Anabel Cámara-Checa Francesca Perin Marcos Rubio-Alarcón María Dago Teresa Crespo-García | 2023/12/5 |
Tratamiento de la hipertrigliceridemia con icosapento de etilo en pacientes de alto/muy alto riesgo cardiovascular. Documento de consenso de la Sociedad Española de Cardiología … | Endocrinología, Diabetes y Nutrición | Juan Pedro-Botet Vivencio Barrios Víctor Sánchez-Margalet Juan Tamargo Francisco Arrieta | 2023/3/1 |
CE-452779-1 IVABRADINE FOR CONTROLLING HEART RATE IN PERMANENT ATRIAL FIBRILLATION: RESULTS OF THE TRANSLATIONAL CLINICAL TRIAL BRAKE-AF | Heart Rhythm | Adolfo Fontenla Juan Tamargo Ricardo Salgado Maria Lopez-Gil Elena Mejia | 2023/5/1 |
Sex-related differences in benefits of anticoagulation therapy in elderly patients with atrial fibrillation: a subanalysis of the EMERG-AF study | Emergencias | Mercedes Varona Alfonso Martín Juan Sánchez Juan Tamargo Manuel Cancio | 2023/8/1 |
An updated review on the role of non-dihydropyridine calcium channel blockers and beta-blockers in atrial fibrillation and acute decompensated heart failure: evidence and gaps | Jeffrey Triska Juan Tamargo Biykem Bozkurt Uri Elkayam Addison Taylor | 2023/12 | |
A rare gain of function HCN4 gene mutation is responsible for inappropriate sinus tachycardia in a Spanish family | medRxiv | Anabel Cámara-Checa Francesca Perin Marcos Rubio-Alarcón María Dago Teresa Crespo-García | 2023/1/20 |
Ehra expert consensus document on the management of arrhythmias in frailty syndrome, endorsed by the heart rhythm society (hrs), asia pacific heart rhythm society (aphrs … | Europace | Irina Savelieva Stefano Fumagalli Rose Anne Kenny Stefan Anker Athanase Benetos | 2023/4/28 |
Erratum: 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and … | European heart journal cardiovascular Imaging | Alexander R Lyon Teresa López-Fernández Liam S Couch Riccardo Asteggiano Marianne C Aznar | 2023/6/1 |
